Fremont, CA — AnaSpec is pleased to announce the release of a product line of recombinant Protein A, conjugated with HiLyte™ Fluor dyes or Biotin. This universal reagent can be used to detect antibodies from different species, such as human, rabbit, mouse, rat and others. Protein A is available as labeled with HiLyte™ Fluor 488 […]
ST. PAUL –- 3M Food Safety announced today that two of its 3M? Molecular Detection Assays, Listeria monocytogenes and Listeria species, have been approved for First Action Official Method of Analysis SM distinction by AOAC INTERNATIONAL (OMA method numbers 2014.07 and 2014.06, respectively). The scope of the validations cover a variety of food matrices including […]
ST. LOUIS — Sigma-Aldrich Corporation’s (NASDAQ: SIAL) Research business unit, which supports scientific research by supplying products, services and solutions, today announced it has entered into a new gene editing collaboration with the Institute of Molecular Genetics (IMG) at the Czech Center for Phenogenomics (CCP) in Prague. Under the collaboration, Sigma-Aldrich will provide the Transgenic […]
AstraZeneca today announced four research collaborations aimed at harnessing the power of CRISPR, a pioneering genome-editing technique, across its entire discovery platform in the company’s key therapeutic areas. The technology will allow AstraZeneca to identify and validate new drug targets in preclinical models that closely resemble human disease. AstraZeneca will share cell lines and compounds […]
MADISON, WISCONSIN — Promega Corporation announces the release of the PowerPlex® Fusion 6C System, a 6-color, 27-locus multiplex. The system combines common and informative loci to overcome typical challenges faced by laboratories, including sample inhibitors, low levels of input DNA, degradation, and mixtures. The PowerPlex Fusion 6C System includes the 23 loci in the expanded […]
Gothenburg, Sweden — Persomics was founded mid 2014 with a firm ambition to change the way cures are discovered. Based on great technology, Persomics empowers companies and organizations to discover cures faster. Persomics has now closed the first round of funding led by two Swedish business angels, Johan Lassing, CEO of Qamcom Technology AB and […]
Hombrechtikon, Switzerland, San Carlos, CA, Piscataway, NJ -— PreAnalytiX GmbH, NuGEN Technologies, Inc. and RUCDR Infinite Biologics (RUCDR), today announced a joint project to validate an end-to- end workflow for the reproducible collection and processing of whole blood for RNA sequencing (RNA-Seq) in clinical studies. The multi-site validation study involves three independent laboratories processing samples […]
Ipswich, MA -– New England Biolabs (NEB®) today announced the release of its new Rapid PNGase F glycosidase at the 2015 WCBP Meeting in Washington, DC. This broad-specificity glycosidase completely removes N-glycans from antibodies and fusion proteins in 10 minutes or less. This important technical advancement offers the potential to accelerate the quality control analysis […]
AMSBIO has announced the availability of ultra specific and extensively validated monoclonal antibodies under the UltraMAB™ brand. Screening of candidate antibodies against greater than 10,000 human proteins, using a state-of-the-art High Density Protein Microarray Platform, has resulted in the identification of the most specific monoclonal antibodies (UltraMAB antibodies) available for cancer biomarkers and other important […]
ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT: BTX) announced today the issuance of 14 new patents covering a wide range of the core technologies of BioTime and its subsidiaries Asterias Biotherapeutics, Inc. (NYSE MKT: AST), OrthoCyte Corporation, ES Cell International Pte Ltd, OncoCyte Corporation, and ReCyte Therapeutics, Inc. The new patents issued over Q3 and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
